Author:
Holoye Paul Y.,Jeffries Diane G.,Dhingra Hari M.,Holmes Frankie A.,Raber Martin,Engineer Meher S.,Newman Robert A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference11 articles.
1. Alberts DS, Chen HSG, Mayersohn M, Perrier D, Moon TE, Gross JF (1979) Bleomycin pharmacokinetics in man: II. Intracavitary administration. Cancer Chemother Pharmacol 2: 127
2. Clarkson B, O’Connor A, Winston L, Hutchison D (1966) The physiologic disposition of 5-fluorouracil and 5-fluoro-2′-deoxyuridine in man. J Clin Pharmacol Ther 5: 581
3. D’Incalci M, Farina P, Sessa C, Mangioni C, Conter V, Masera G, Rocchetti M, Brambilla Pisoni M, Piazza E, Beer M, Cavalli F (1982) Pharmacokinetics of VP-16-123 given by different administration methods. Cancer Chemother Pharmacol 7: 141
4. Evans WE, Sinkule JA, Crom WR, Dow L, Look AT, Rivera G (1982) Pharmacokinetics of teniposide (VM-26) and etoposide (VP-16-213) in children with cancer. Cancer Chemother Pharmacol 7: 147
5. Howell SB, Chu BBF, Wung WE, Metha BM, Mendelsohn J (1981) Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions. J Clin Invest 67: 1161
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献